N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial
Zhi Wei Lai, Robert Hanczko, Eduardo Bonilla, Tiffany N. Caza, Brandon Clair, Adam Bartos, Gabriella Miklossy, John Jimah, Edward Doherty, Hajra Tily, Lisa Francis, Ricardo Garcia, Maha Dawood, Jianghong Yu, Irene Ramos, Ioana Coman, Stephen V. Faraone, Paul E. Phillips, Andras Perl
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.